208 related articles for article (PubMed ID: 38501105)
1. Advances in targeted therapy and biomarker research in thyroid cancer.
Guo M; Sun Y; Wei Y; Xu J; Zhang C
Front Endocrinol (Lausanne); 2024; 15():1372553. PubMed ID: 38501105
[TBL] [Abstract][Full Text] [Related]
2. Omics sciences and precision medicine in thyroid cancer.
Dhuli K; Medori MC; Donato K; Donato K; Maltese PE; Tanzi B; Tezzele S; Mareso C; Miertus J; Generali D; Donofrio CA; Cominetti M; Fioravanti A; Riccio L; Beccari T; Ceccarini MR; Stuppia L; Stuppia L; Gatta V; Cristoni S; Cecchin S; Marceddu G; Bertelli M
Clin Ter; 2023; 174(Suppl 2(6)):11-20. PubMed ID: 37994744
[TBL] [Abstract][Full Text] [Related]
3. Exploitation of Gene Expression and Cancer Biomarkers in Paving the Path to Era of Personalized Medicine.
Kamel HFM; Al-Amodi HSAB
Genomics Proteomics Bioinformatics; 2017 Aug; 15(4):220-235. PubMed ID: 28813639
[TBL] [Abstract][Full Text] [Related]
4. Precision Medicine Approach to Anaplastic Thyroid Cancer: Advances in Targeted Drug Therapy Based on Specific Signaling Pathways.
Samimi H; Fallah P; Naderi Sohi A; Tavakoli R; Naderi M; Soleimani M; Larijani B; Haghpanah V
Acta Med Iran; 2017 Mar; 55(3):200-208. PubMed ID: 28282720
[TBL] [Abstract][Full Text] [Related]
5. Current status of biomarker testing in historically rare, high-unmet-need tumors: soft tissue sarcomas and thyroid cancers.
Schroader B; Kong S; Anderson S; Williamson T; Sireci A; Shields K
Expert Rev Anticancer Ther; 2019 Nov; 19(11):929-938. PubMed ID: 31622558
[No Abstract] [Full Text] [Related]
6. Molecular diagnosis and targeted treatment of advanced follicular cell-derived thyroid cancer in the precision medicine era.
Capdevila J; Awada A; Führer-Sakel D; Leboulleux S; Pauwels P
Cancer Treat Rev; 2022 May; 106():102380. PubMed ID: 35305441
[TBL] [Abstract][Full Text] [Related]
7. Distress, illness perception and coping style among thyroid cancer patients after thyroidectomy: A cross-sectional study.
Zhao X; Bie F; Luo C; Zhang JE
Eur J Oncol Nurs; 2024 Apr; 69():102517. PubMed ID: 38340645
[TBL] [Abstract][Full Text] [Related]
8. Incidence of papillary thyroid cancer: Comparison of the military and the general population by race and tumor stage/size.
Bytnar JA; Enewold L; Shriver CD; Zhu K
Cancer Epidemiol; 2024 Apr; 89():102539. PubMed ID: 38340498
[TBL] [Abstract][Full Text] [Related]
9. Anxiety and Depression as Potential Predictors for Shorter Time to Undergo Initial Surgical Treatment for Papillary Thyroid Cancer.
Vujovic D; Alsen M; Vasan V; Genden E; van Gerwen M
Cancers (Basel); 2024 Jan; 16(3):. PubMed ID: 38339296
[TBL] [Abstract][Full Text] [Related]
10. Optimizing Levothyroxine Replacement: A Precision Dosage Model for Post-Thyroidectomy Patients.
Yang G; Pu J; Zhu S; Shi Y; Yang Y; Mao J; Sun Y; Zhao B
Int J Gen Med; 2024; 17():377-386. PubMed ID: 38322508
[TBL] [Abstract][Full Text] [Related]
11. Thyroid Cancer: A Review.
Boucai L; Zafereo M; Cabanillas ME
JAMA; 2024 Feb; 331(5):425-435. PubMed ID: 38319329
[TBL] [Abstract][Full Text] [Related]
12. Application of carbon nanoparticles in endoscopic thyroid cancer surgery: a systematic review and meta-analysis.
He J; Sun P; Lin J; Shen J; Lin H; Jiang H; Qiu R; Lin E; Lu Y
Front Surg; 2023; 10():1283573. PubMed ID: 38259977
[TBL] [Abstract][Full Text] [Related]
13. Tyrosine Kinase Inhibitors for Radioactive Iodine Refractory Differentiated Thyroid Cancer.
Cortas C; Charalambous H
Life (Basel); 2023 Dec; 14(1):. PubMed ID: 38255638
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
